Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
06/30/2018 | Q2 2018 | N/A | -$1.13 | N/A | N/A | $35.00 M |
03/31/2018 | Q1 2018 | N/A | -$0.92 | N/A | N/A | $50.00 M |
12/31/2017 | Q4 2017 | N/A | -$0.95 | N/A | N/A | $109.00 M |
09/30/2017 | Q3 2017 | N/A | -$0.87 | N/A | N/A | $121.00 M |
06/30/2017 | Q2 2017 | N/A | -$0.94 | N/A | N/A | $112.00 M |
03/30/2017 | Q1 2017 | N/A | -$1.25 | N/A | N/A | $114.00 M |
12/30/2016 | Q4 2016 | N/A | -$2.48 | N/A | N/A | $72.00 M |
09/29/2016 | Q3 2016 | N/A | -$0.50 | N/A | N/A | $197.00 M |
06/29/2016 | Q2 2016 | N/A | -$0.22 | N/A | N/A | $196.00 M |
03/30/2016 | Q1 2016 | N/A | -$0.56 | N/A | N/A | $157.00 M |
12/30/2015 | Q4 2015 | N/A | -$0.92 | N/A | N/A | $123.00 M |
09/29/2015 | Q3 2015 | N/A | -$0.84 | N/A | N/A | $169.00 M |
06/29/2015 | Q2 2015 | N/A | -$1.21 | N/A | N/A | $237.00 M |
03/30/2015 | Q1 2015 | N/A | $0.40 | N/A | N/A | $261.00 M |
12/30/2014 | Q4 2014 | N/A | -$0.65 | N/A | N/A | $180.00 M |
09/29/2014 | Q3 2014 | N/A | $4.00 | N/A | N/A | $152.00 M |
06/29/2014 | Q2 2014 | N/A | -$1.02 | N/A | N/A | $196.00 M |
03/30/2014 | Q1 2014 | N/A | -$0.73 | N/A | N/A | $517.00 M |
12/30/2013 | Q4 2013 | N/A | $0.78 | N/A | N/A | $675.00 M |
09/29/2013 | Q3 2013 | N/A | -$0.91 | N/A | N/A | $615.00 M |
Park Ha Biological Technology Co., Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 29th, 2018 based offlast year's report dates.
In the previous quarter, Park Ha Biological Technology Co., Ltd. (:PHH) reported $-1.07136 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.3548 by $0.28344.
The conference call for Park Ha Biological Technology Co., Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Park Ha Biological Technology Co., Ltd.'s latest earnings report can be read online.
Park Ha Biological Technology Co., Ltd. (:PHH) has a recorded annual revenue of $2.38 M.
Park Ha Biological Technology Co., Ltd. (:PHH) has a recorded net income of $478.56 K.Park Ha Biological Technology Co., Ltd. has generated $0.0183 earnings per share over the last four quarters.
Park Ha Biological Technology Co., Ltd. (:PHH) has a price-to-earnings ratio of 29.46 and price/earnings-to-growth ratio is 0.29.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED